Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Share-based Compensation: 2023-2024

Historic Share-based Compensation for Upstream Bio (UPB) over the last 2 years, with Dec 2024 value amounting to $6.0 million.

  • Upstream Bio's Share-based Compensation rose 39.24% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.9 million, marking a year-over-year increase of 109.51%. This contributed to the annual value of $6.0 million for FY2024, which is 75.20% up from last year.
  • Per Upstream Bio's latest filing, its Share-based Compensation stood at $6.0 million for FY2024, which was up 75.20% from $3.4 million recorded in FY2023.
  • Upstream Bio's Share-based Compensation's 5-year high stood at $6.0 million during FY2024, with a 5-year trough of $3.4 million in FY2023.
  • Its 2-year average for Share-based Compensation is $4.7 million, with a median of $4.7 million in 2023.
  • Data for Upstream Bio's Share-based Compensation shows a peak YoY soared of 75.20% (in 2024) over the last 5 years.
  • Over the past 2 years, Upstream Bio's Share-based Compensation (Yearly) stood at $3.4 million in 2023, then spiked by 75.20% to $6.0 million in 2024.